Byterna Therapeutics
Contact Us

PROGRAMMABLE RNA THERAPEUTICS

Programming immunity
in vivo with
circular mRNA.

Two therapeutic programs connect circular mRNA, cell-selective delivery, computational design and integrated CMC within one development system.

Planned expansion direction: Autoimmune diseases.

Explore our platform ↗Explore our pipeline ↗

TWO LEAD DIRECTIONS · SELECTIVE EXPANSION

A focused pipeline.
Disciplined expansion.

View detailed pipeline ↗

In vivo CAR-T

Circular mRNA and cell-selective CellectLNP delivery support transient, non-integrating immune-cell programming in vivo.

Explore program

Neoantigen Cancer Vaccine

AI ranks and optimizes patient-specific neoantigen combinations, linking tumor data to circular mRNA vaccine design and manufacturing.

Explore program

Other In vivo mRNA Medicines

Programs advance selectively where programmable expression and targeted delivery can create differentiated therapeutic value.

Explore program
SHARED DEVELOPMENT ENGINE

AI-enabled design · circular mRNA · cell-selective delivery · CMC & manufacturing

PROGRAMMABLE IMMUNITY

Patient data, RNA and manufacturing—
connected by evidence.

In vivo CAR-T delivers RNA instructions that program selected immune cells. Personalized cancer vaccines supply patient-specific antigen information to direct immune recognition. Both are supported by a shared translational system.

Neodiscovery.ai

Ranks and optimizes combinations of patient-specific neoantigens, linking tumor data to circular mRNA vaccine design.

Explore platform ↗

CellectLNP Delivery

Designed to link antibody-directed targeting with biodistribution, intended-cell expression and tolerability.

Explore platform ↗

Circular mRNA

A covalently closed RNA architecture developed for program-specific expression, product quality and manufacturability.

Explore platform ↗

NEWS & PERSPECTIVES

Company progress.
Scientific perspective.

View all news ↗

INVESTORS

Backing long-horizon science.

Meet the investors and strategic partners supporting Byterna's mission.

CAREERS

Build at the AI–biology interface.

Join an R&D team integrating computational design, RNA engineering, targeted delivery and CMC to build proprietary in vivo mRNA medicines.

Explore how your experience in AI, data science, therapeutic development or experimental research could contribute to our work.

Explore Join Us